Search

everythinglearnresearchcommunity

for

Search:↓

Using normal saline in vertical extraction for hair transplants reduces donor area injury more than acute extraction.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

A man regrew hair in 15 days using Pracchana and cupping therapy.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Current treatments for alopecia show no significant long-term benefits.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Minoxidil helps hair regrowth in alopecia patients, with 16 having good results and no side effects.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Baricitinib is effective and safe for treating severe alopecia areata.

PRP more effective than minoxidil 5% for treating alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.